Effect of hormonal contraceptives on lipid profile and the risk indices for cardiovascular disease in a Ghanaian community

References

• Lloyd-JonesDMHongYLabartheDAmerican Heart Association Strategic Planning Task Force and Statistics CommitteeDefining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic Impact Goal through 2020 and beyondCirculation2010121458661320089546
   PubMed Web of Science ®Google Scholar
• World Health OrganizationGlobal health risks: mortality and burden of disease attributable to selected major risksGeneva, SwitzerlandWorld Health Organization200928 Available at: http://www.who.int/healthinfo/global_burden_disease/GlobalHealthRisks_report_full.pdfAccessed April 28, 2014
   Google Scholar
• ParryCDPatraJRehmJAlcohol consumption and non-communicable diseases: epidemiology and policy implicationsAddiction2011106101718172421819471
   PubMed Web of Science ®Google Scholar
• World Health OrganizationGlobal Atlas on cardiovascular disease prevention and controlGeneva, SwitzerlandWorld Health Organization2011136 Available at: http://www.world-heart-federation.org/fileadmin/user_upload/documents/Publications/Global_CVD_Atlas.pdfAccessed April 28, 2014
   Google Scholar
• KhanMMensahGAEpidemiology of Cardiovascular Disease. In: Institute of Medicine (US) Committee on Preventing the Global Epidermic of Cardiovascular Disease: Meeting the Challenges in Developing CountriesFusterVKellyBBPromoting Cardiovascular Health in the Developing World: A Critical Challenge to Achieve Global HealthWashington, DCNational Academies Press201049124
   Google Scholar
• TsismenakisAJChristophiCABurressJWKinneyAMKimMKalesSNThe obesity epidemic and future emergency respondersObesity20091781648165019300435
   PubMed Web of Science ®Google Scholar
• NelmsMSucherKPLacyKRothSLNutrition Therapy and Pathophysiology2nd edBelmont, CACengage Learning, Inc2010
   Google Scholar
• JonesDRSchmidtRJPickardRTFoxworthyPSEachoPIEstrogen receptor-mediated repression of human hepatic lipase gene transcriptionJ Lipid Res200243338339111893774
   PubMed Web of Science ®Google Scholar
• EndrikatJKlippingCCroninMAn open label, comparative study of the effects of a dose-reduced oral contraceptive containing 20 microg ethinyl estradiol and 100 microg levonorgestrel on hemostatic, lipids, and carbohydrate metabolism variablesContraception200265321522111929643
   PubMed Web of Science ®Google Scholar
• BarkfeldtJVirkkunenADiebenTThe effects of two progestogen-only pills containing either desogestrel (75 microg/day) or levonorgestrel (30 microg/day) on lipid metabolismContraception200164529529911777489
   PubMed Web of Science ®Google Scholar
• EnkLLandgrenBMLindbergUBSilfiverstolpeGCronaNA prospective, one-year study on the effects of two long acting injectable contraceptives (depot-medroxyprogesterone acetate and norethisterone oenanthate) on serum and lipoprotein lipidsHorm Metab Res199224285891533383
   PubMed Web of Science ®Google Scholar
• CrookDGodslandIFWynnVOral contraceptives and coronary heart disease: modulation of glucose tolerance and plasma lipid risk factors by progestinsAm J Obstet Gynecol19881586 Pt 2161216203287933
   PubMed Web of Science ®Google Scholar
• WatanabeRMAzenCGRoySPerlmanJABergmanRNDefects in carbohydrate metabolism in oral contraceptive users without apparent metabolic risk factorsJ Clin Endocrinol Metab1994795127712837962320
   PubMed Web of Science ®Google Scholar
• AkpaluJAkpaluAOfeiFThe metabolic syndrome among patients with cardiovascular disease in Accra, GhanaGhana Med J201145416116622359422
   PubMedGoogle Scholar
• GyakoboMAmoahAGMartey-MarbellDASnowRCPrevalence of the metabolic syndrome in a rural population in GhanaBMC Endocr Disord2012122523110418
   PubMed Web of Science ®Google Scholar
• KemperEStringfieldSTeddlieCMixed methods sampling strategies in social science researchTashakkoriATeddlieCHandbook of Mixed Methods in Social and Behavioral ResearchThousand Oaks, CASage2003273296
   Google Scholar
• LubiancaJNFaccinCSFuchsFDOral contraceptives: a risk factor for uncontrolled pressure among hypertensive womenContraception2003671192412521653
   PubMed Web of Science ®Google Scholar
• LubiancaJNMoreiraLBGusMFuchsFDStopping oral contraceptives: an effective blood pressure-lowering intervention in women with hypertensionJ Hum Hypertens200519645145515759027
   PubMed Web of Science ®Google Scholar
• DuYRosnerBMKnopfHSchwarzSDörenMScheidt-NaveCHormonal contraceptive use among adolescent girls in Germany in relation to health behavior and biological cardiovascular risk factorsJ Adolesc Health201148433133721402260
   PubMed Web of Science ®Google Scholar
• TepperNKCurtisKMSteenlandMWMarchbanksPABlood pressure measurement prior to initiating hormonal contraception: a systematic reviewContraception201387563163823063336
   PubMed Web of Science ®Google Scholar
• BritoMBNobreFVieiraCSHormonal contraception and cardiovascular systemArq Bras Cardiol2011964e81e8921359483
   PubMed Web of Science ®Google Scholar
• Sitruk-WareRNew progestagens for contraceptive useHum Reprod Update200612216917816291771
   PubMed Web of Science ®Google Scholar
• MiaARSiddiquiNIIslamMNKhanMRShampaSSRukunuzzamanMEffects of prolonged use of injectable hormonal contraceptive on serum lipid profileMymensingh Med J2005141192115695947
   PubMedGoogle Scholar
• JosseARGarcia-BailoBFischerKEl-SohemyANovel effects of hormonal contraceptive use on the plasma proteomePLoS One201279e4516222984625
   PubMed Web of Science ®Google Scholar
• OkekeCUBraideSAOkolonkwoBNComparative effects of injectable and oral hormonal contraceptives on lipid profileEur J Cardio Med2012212023
   Google Scholar
• NessaALatifSAUddinMMHussainMASerum HDL-cholesterol in women using low dose oral contraceptivesMymensingh Med J200716Suppl 2S3S617917628
   PubMedGoogle Scholar
• BerensonABRahmanMWilkinsonGEffect of injectable and oral contraceptives on serum lipidsObstet Gynecol2009114478679419888036
   PubMed Web of Science ®Google Scholar
• MainaFWSekadde-KigonduCBOjwangPJMatiJKChanges in plasma HDL-cholesterol in women using oral contraceptives in KenyaEast Afr Med J19876474424473691360
   PubMed Web of Science ®Google Scholar
• FrempongBARicksMSenSSumnerAEEffect of low-dose oral contraceptives on metabolic risk factors in African-American womenJ Clin Endocrinol Metab20089362097210318334585
   PubMed Web of Science ®Google Scholar
• PantojaMMedeirosTBaccarinMCMoraisSFernandesAMVariation of weight among users of the contraceptive with depot-medroxyprogesterone acetate according to body mass index in a six-year follow-upRev Bras Ginecol Obstet2009318380384 Portuguese19838585
   PubMedGoogle Scholar
• PiccoliACrosignaniPNappiCRonsiniSBruniVMarelliSItalian EVRA Contrast Study GroupEffect of the ethinylestradiol/norelgestromin contraceptive patch on body composition. Results of bioelectrical impedance analysis in a population of Italian womenNutr J200872118727825
   PubMed Web of Science ®Google Scholar
• LindhIEllströmAAMilsomIThe long-term influence of combined oral contraceptives on body weightHum Reprod20112671917192421507999
   PubMed Web of Science ®Google Scholar
• OddensBJVisserAPVemerHMEveraerdWTLehertPContraceptive use and attitudes in Great BritainContraception199449173868137627
   PubMed Web of Science ®Google Scholar
• WysockiSA survey of American women regarding the use of oral contraceptives and weight gainInt J Gynecol Obstet200070Suppl 1114
   Google Scholar
• YusufSHawkenSOunpuuSINTERHEART Study InvestigatorsEffect of potentially modifable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control studyLancet2004364943893795215364185
   PubMed Web of Science ®Google Scholar
• OyelolaOOFasting plasma lipid, lipoproteins and apolipoproteins in Nigerian women using combined oral and progestin-only injectable contraceptivesContraception19934754454548513671
   PubMed Web of Science ®Google Scholar